Sentiment Summary
Recent Events
Q2 2026 earnings release is scheduled. A low market impact is estimated as the specific financial results are not yet disclosed.
Amazon's Q2 2026 earnings release is expected on July 30, 2026. The company guided for net sales between $194.0 billion and $199.0 billion. Low importance is assigned as the market reaction has not yet occurred expected.
Meta Platforms is expected to release its Q2 2026 financial results after market close on July 29, 2026. Due to historical volatility during earnings for mega-cap tech stocks, a high price impact (>10%) is expected.
Lam Research is expected to report its Q4 2026 earnings on July 29, 2026. Analysts forecast an EPS of approximately $1.65-$1.68. Market impact is estimated at Medium as earnings reports typically drive significant price volatility, scheduled.
Alphabet Q2 2026 earnings release scheduled for July 22, 2026, with analysts forecasting EPS of approximately $2.85-$2.87 forecasted.
IBM's Q2 2026 earnings announcement is scheduled for July 22, 2026, scheduled
Q2 2026 earnings release and conference call scheduled. Market impact is estimated to be low (>=1%) as a routine announcement scheduled.
Q2 2026 earnings release, importance estimated as High as earnings reports are major catalysts for stock price movement, scheduled.
Q2 2026 earnings release scheduled. Analysts forecast EPS of approximately $0.79. The company has guided for 13% revenue growth and a 32.6% operating margin for the quarter; impact is neutral as the market awaits actual results scheduled.
Abbott is expected to announce its Q2 2026 earnings results on July 16, 2026. This key quarterly financial update is estimated to have a moderate price impact of at least 5%, scheduled.
Ex-dividend date of 2026-07-03 for a proposed final dividend of RMB 0.295 per share for the year ended Dec 31, 2025, with payment on 2026-08-21 following approval on 2026-06-30; the dividend is expected to have a price impact of at least 1% scheduled
Confirmed planned spin-off/distribution of Honeywell Aerospace from Honeywell International Inc.; Honeywell Aerospace is expected to begin trading on Nasdaq as HONA, and the remaining company is expected to be renamed Honeywell Technologies and continue trading as HON. This qualifies as a trading issue because it is a confirmed corporate action affecting Honeywell shareholders through a share distribution/spin-off.
Ex-dividend date for the final 2025 dividend for H-shares on June 29, 2026 scheduled; the dividend event is estimated to have a low price impact.
Annual General Meeting on June 26, 2026, to approve 2025 results and dividends. Analysts estimate a 1-5% price impact for this routine corporate event scheduled.
The company will host a Masterclass webcast on DRAM and advanced packaging on June 25, 2026. Medium importance is estimated as technical masterclasses can reveal significant roadmap updates driving >= 5% price impact, scheduled.
Ex-dividend date for the final dividend of RMB 5.30 per 10 shares for the fiscal year 2025. The dividend is scheduled to be paid on July 24, 2026.
Micron Technology is scheduled to report its fiscal third-quarter 2026 financial results on June 24, 2026, which is expected to have a significant price impact due to strong AI memory chip demand and positive forward guidance, scheduled.
2025 Annual General Meeting (AGM) and subsequent class meetings to be held in Qingdao on June 24, 2026 to approve the annual report and dividend plan scheduled; the routine meeting is estimated to have a low price impact.
The annual Prime Day shopping event is scheduled to begin on June 23, 2026, running for an expanded four-day period until June 26, 2026. This is expected to boost Q2 retail sales. Medium importance is estimated based on historical revenue impact scheduled.
Quarterly dividend of $0.25 per share, with an ex-dividend date of June 23, 2026, and payable on July 15, 2026.
The ex-dividend date for the final 2025 dividend of RMB 4.11 per 10 shares on 2026-06-22 scheduled. Low impact estimated as cash dividend distributions typically result in minor market adjustments.
Ex-dividend date for a quarterly cash dividend of $0.65 per share on June 22, 2026. This routine corporate action, with payment on June 30, 2026, typically results in a minor price adjustment of approximately 1% expected.
GigaDevice Semiconductor Inc. inclusion in the FTSE China A50 Index, effective after the market close on June 18, 2026; inclusion in a major index typically triggers significant passive buying scheduled.
Quarterly dividend ex-date for a payment of $0.26 per share, as declared on May 21, 2026.
Meta declared a quarterly cash dividend of $0.525 per share, with an ex-dividend date of June 15, 2026. This dividend announcement is estimated to have a low price impact (>=1%).
Final dividend for FY2025 of RMB 1.65 per 10 shares. The ex-dividend date is June 12, 2026, with payment on July 16, 2026. High importance estimated due to significant dividend yield impacting investor demand, scheduled
KLA's 10-for-1 stock split takes effect on June 12, 2026, with split-adjusted trading beginning that day; shareholders of record on June 4, 2026 receive nine additional shares after the close on June 11, 2026, scheduled
Midea Group will pay an annual dividend of ¥3.50 per share, with the ex-dividend date on June 12, 2026; the payout offers a steady yield for investors, scheduled.
Amie Thuener is scheduled to succeed Kirsten Spears as Chief Financial Officer, effective June 12, 2026. This executive transition, announced on April 2, 2026, is expected to have a low market impact scheduled.
Ex-dividend date for BYD's 2025 final cash dividend of RMB 0.358 per H-share on June 11, 2026; Low importance justified by typical dividend price adjustment of >1% scheduled.
Ex-dividend date for the final dividend of HKD 0.156 for the year ended December 31, 2025, scheduled for 2026-06-11; low importance as dividends typically have minor price impact.
Quarterly cash dividend of $0.44 per share with an ex-dividend date of June 11, 2026; low importance as dividends typically have minimal price impact scheduled.
Investor day for Honeywell Technologies (RemainCo) on June 11, 2026. Low importance is estimated as investor days typically have limited immediate price impact, scheduled.
Q4 2026 earnings release scheduled. Analysts forecast strong performance in the cloud computing segment, driven by AI demand, with an expected EPS of $1.96 on $19.1 billion in revenue. High importance due to potential for significant price impact forecasted.
Alibaba's annual dividend for fiscal year 2026 has an ex-dividend date of June 10, 2026. The dividend is approximately HK$1.03 per share.
Apple's annual Worldwide Developers Conference (WWDC) is scheduled to begin on 2026-06-08, with major announcements expected for new software versions like iOS 27 and AI advancements; analysts estimate a 5% price impact based on historical trends scheduled.
Listing of 324,450 shares from the third restricted stock incentive plan for 69 employees on June 8, 2026, scheduled.
Honeywell Technologies (RemainCo) 2026 outlook update call on June 8, 2026. Low importance is estimated for this routine financial update, scheduled.
Ex-dividend date (June 5, 2026) for the 2025 final cash dividend of HKD 1.206 per share. Payment is scheduled for June 26, 2026. A price impact of approximately 2% is expected based on the dividend yield.
Alphabet held its 2026 Annual Meeting of Shareholders on June 5, 2026. Proposals included an increase to the 2021 Stock Plan share reserve.
Announcement that CLDN18.2 ADC IBI343 (arcotatug tavatecan) met Phase 3 primary endpoint in gastric cancer and NDA was accepted by NMPA; >10% price impact estimated due to first-in-class status expected
Completed the full circulation of H-shares, with 373,841,270 domestic unlisted shares converted to H-shares and listed for trading on the Hong Kong Stock Exchange on June 4, 2026.
The company presented positive Phase III trial data for its 'Defu Combination' (Anlotinib plus Bemotuzumab) as a first-line treatment for non-squamous non-small cell lung cancer (nsq-NSCLC) at the 2026 ASCO meeting, showing a significant 6-month improvement in median Progression-Free Survival (mPFS) compared to the control group.
Announced a major investment initiative of over €10 billion on June 4, 2026, to modernize its European fulfillment network with advanced robotics and to accelerate international delivery services. The plan includes creating 25,000 new jobs.
Gilead announced the successful completion of the acquisition of Ouro Medicines on 2026-06-04, adding gamgertamig to its inflammation pipeline; Medium importance estimated as it strengthens the portfolio, expected.
IBM and Google Cloud announced a strategic partnership on June 4, 2026, to launch a new Google Cloud Practice within IBM Consulting to help scale enterprise AI solutions using Google's Gemini models.
Announced repurchase of 812,400 H-shares for approximately HK$101 million on June 4, 2026, as part of an ongoing share buyback program; low importance as the buyback is routine and likely to result in >=1% price impact.
The company announced on June 4, 2026, that it had repurchased 34,000 of its own shares for approximately HK$6.46 million. Low importance estimated due to the relatively small buyback size compared to market capitalization; scheduled.
The May 2026 Steam Hardware Survey showed AMD's CPU market share among users increased by 0.79% month-over-month to 44.97%, while its GPU share also saw a slight increase to 19.13%. Low importance justified by incremental market share gains likely causing ≥1% price impact.
Pinterest announced a new agreement on June 4, 2026, to spend $4 billion on Amazon Web Services (AWS) cloud services through 2031, highlighting continued major customer commitments to the AWS platform.
Annual Meeting of Stockholders held on June 4, 2026.
Quarterly dividend of $0.92 per share (an increase from $0.89) went ex-dividend on June 4, 2026, payable on June 25, 2026. Low impact expected as the increase aligns with historical growth patterns.
The New Drug Application (NDA) for Olipudase (奥莱泊肽), a GLP-1/GIP dual receptor agonist, was accepted for review by China's NMPA on June 3, 2026. Analysts estimate a >10% price impact due to the drug's significant market potential expected.
Broadcom reported Q2 2026 revenue of $22.2B and non-GAAP EPS of $2.44 on June 3, 2026, beating analyst estimates. However, the stock fell over 14% in after-hours trading as its Q3 AI revenue guidance of ~$16B fell short of elevated investor expectations.
BYD and Sinopec strategic cooperation framework agreement to build a flash charging station network; Medium importance justified by strategic value likely causing >5% price impact scheduled.
The company announced positive interim data from a Phase II study of Ivonescimab for first-line metastatic colorectal cancer (mCRC) at ASCO 2026, showing a 70.8% objective response rate and 100% disease control rate. Medium importance is estimated as Phase II data typically results in a 5-10% price impact scheduled.
On June 3, 2026, it was reported that Wu Zeming was appointed to the Alibaba Partnership Committee, a key governance body. This follows an April announcement of a new Technology Committee to accelerate AI development.
Presented new Phase 3 data for UPLIZNA at the EULAR 2026 Congress, showing a 0% flare rate over one year in patients with IgG4-Related Disease who continued treatment. Medium importance as positive clinical data supports market share, expected.
Salesforce to unveil a new suite of autonomous AI agents at its Connections event on June 3, 2026; medium importance estimated for significant product launch scheduled.
Johnson & Johnson announced on June 3, 2026, that its monoclonal antibody, nipocalimab, met the primary endpoint in the Phase 2 JASMINE study for SLE; positive clinical data for a major pipeline candidate is estimated to have a 5-10% market impact, expected.
It was reported on June 3, 2026, that the U.S. FTC broadened its antitrust probe into Microsoft's cloud and AI practices. Medium importance is estimated based on the typical 5% market reaction to increased regulatory scrutiny.
On June 3, 2026, Midea announced it had repurchased 42.98 million A-shares (0.56% of capital) for CNY 3.42 billion; the small scale suggests limited price impact, expected.
ZTE strategic cooperation with Tencent to launch an AI-powered cloud PC on 2026-06-03 scheduled. Low impact estimated as the immediate financial contribution from the partnership is expected to be limited.
The UK's Competition & Markets Authority (CMA) announced on June 3, 2026, new conduct requirements for Google's AI-powered search, giving publishers more control over their content.
Hosted an investor day for the upcoming Honeywell Aerospace spin-off company on June 3, 2026, outlining its strategy and financial targets. The stock price fell 3.55% on this day.
On June 3, 2026, Meta unveiled an enterprise AI agent for businesses on its messaging platforms, aiming to compete in the enterprise AI market. The stock rose over 3% following the announcement.
Investor Michael Burry reiterated his bearish view on Palantir stock on June 3, 2026, calling it a "sand castle" and citing a topping pattern in the stock's chart.
RTX's Raytheon business was awarded a $515 million contract modification from the U.S. Navy for continued support and upgrades for the SPY-6 family of radars.
Mr. Xu Feng resigned as an Independent Non-Executive Director, Chairman of the Nomination Committee, and a member of the Strategic and Remuneration Committees on June 2, 2026. This high-level departure is estimated to cause a ≥10% price impact due to potential concerns over corporate governance, expected.
The company's commencement of an automatic share repurchase program of up to US$500 million, starting June 2, 2026. This large buyback is expected to have a high price impact (≥10%) by significantly reducing share supply, scheduled.
Stock surged over 10% on June 2, 2026, driven by reports that Tencent is finalizing testing of an AI agent integrated into WeChat, with a compliance review expected to start as early as June.
Microsoft held its Build 2026 conference from June 2-3, 2026, unveiling AI updates like the Microsoft IQ intelligence layer, Autopilots agents, and a Mayo Clinic collaboration. High importance is estimated as major AI platform launches typically drive significant market valuation changes.
Kelun-Biotech announced positive first-in-human study results for its novel B7-H3 ADC drug, SKB500, at the 2026 ASCO annual meeting on June 2, 2026. The data showed broad-spectrum antitumor activity across multiple solid tumors, with notable efficacy in small cell lung cancer (SCLC).
Goldman Sachs lowered its price target for Horizon Robotics to HK$13.14 from HK$15.30 while maintaining a "Buy" rating and revised its earnings forecasts for 2026 and 2027, estimated.
Announced positive results from the Phase 3 IDEAL study for Livdelzi on 2026-06-02; Medium importance estimated due to high probability of future approval, expected.
Palo Alto Networks is expected to report fiscal Q3 2026 results on June 2, 2026. Analysts forecast revenue of $3.0 billion and non-GAAP EPS of $0.85, which would beat previous estimates. Importance is Medium as an earnings beat and raised guidance typically result in a 5-10% price impact. expected
Ex-dividend date on June 2, 2026, for the final dividend of HK$0.024 per share for the year ended December 31, 2025, is scheduled; the dividend was approved on May 29, 2026, and is payable by June 26, 2026; the payout is estimated to have a market impact of over 1%, justifying Low importance.
Held its Annual General Meeting on June 2, 2026, where shareholders approved all resolutions, including the re-election of directors and general mandates for share repurchases and the issuance of new shares.
Announced the establishment of a RMB 1.6 billion equity investment fund in Hubei with partners including Go-tion, Nord, and Hymson, with CALB being the largest contributor at RMB 799 million.
Quarterly dividend of $1.10 per share went ex-dividend on June 2, 2026, with payment scheduled for June 16, 2026. Low price impact is expected.
CFO Brice Hill presented at the BofA Securities Global Technology Conference on June 2, 2026, reiterating a strong growth outlook. Low importance is estimated as reiterating existing outlook typically has >= 1% price impact, scheduled.
RTX's Collins Aerospace business announced the opening of an expanded manufacturing facility in Poland to increase landing gear production capacity by nearly 25%.
Julie Knecht was appointed as the next Chief Financial Officer on June 2, 2026, effective August 1, 2026. Market impact is estimated to be low (>=1%) as internal successions typically maintain stability scheduled.
Akeso announced that its drug Ivonescimab plus chemotherapy showed a 34% reduction in the risk of death in the Phase III HARMONi-6 trial for first-line advanced squamous non-small cell lung cancer. The landmark results were presented at the ASCO 2026 Plenary Session and published in The Lancet. High importance is estimated due to the significant clinical success in a major indication, likely resulting in >10% price impact scheduled.
European Commission granted marketing authorization for IMDYLLTRA (tarlatamab) for the treatment of adults with extensive-stage small cell lung cancer (ES-SCLC) with disease progression on or after platinum-based chemotherapy. High importance due to major drug approval potential, expected.
Alphabet announced an $80 billion equity capital raise on June 1, 2026, to fund AI infrastructure, including a $10 billion investment from Berkshire Hathaway. The offering was upsized to approximately $85 billion on June 3, 2026, due to high demand. This massive capital raise is expected to have a high price impact due to significant dilution.
BYD May 2026 sales figures announcement with record overseas sales of 160,644 units, ending eight months of decline; Medium importance justified by strong growth likely causing >5% price impact expected.
Presentation of positive long-term follow-up data for IBI363 (PD-1/IL-2) at the 2026 ASCO annual meeting; 5-10% price impact estimated due to clinical data validation scheduled
Provided a business update on June 1, 2026, maintaining full-year 2026 revenue growth guidance of 13-17% and reporting 69 new projects; medium importance reflects an estimated price impact of 5% or more.
At Computex 2026 on June 1, 2026, Qualcomm unveiled its 'Dragonfly' brand for data center AI inference chips, signaling a major push into the AI data center market. Medium impact expected due to strategic entry into a high-growth segment.
Independent Non-Executive Director Ms. Cheng Yunfeng was appointed as the chairman of the Audit Committee on June 1, 2026, following the resignation of Ms. Tang Huiyi. Minimal market impact is expected from this routine board change.
Official filing of a private equity fund with RMB 400 million investment from the company on June 1, 2026; this is a standard administrative milestone for the investment scheduled.
Ex-dividend date for a $3.45 quarterly dividend on June 1, 2026; analysts forecast a ~1% price impact, which is estimated and scheduled.
NVIDIA unveiled the RTX Spark PC superchip and expanded its Microsoft collaboration to push AI-first Windows PCs on 2026-06-01, a strategic PC-market entry that likely had an about 1% to 2% near-term share-price effect based on reported market reaction.
Announced two breakthroughs: its innovative peptide food ingredient, Tensotide, received US Self-GRAS certification, and its incubated company's solid tumor drug, SIGX2649, received US FDA IND approval.
The company announced on May 31, 2026, that its Phase III study (OptiTROP-Lung05) of sacituzumab tirumotecan (sac-TMT) combined with pembrolizumab for first-line treatment of PD-L1 positive NSCLC met its primary endpoint.
Announced several new products at Computex 2026, including the Ryzen 7 7700X3D and a Ryzen 7 5800X3D Anniversary Edition CPU, the global launch of the Radeon RX 9070 GRE GPU, and extended support for the AM5 platform through 2029. Medium importance justified by major product launches likely causing ≥5% price impact.
On May 31, 2026, Johnson & Johnson announced positive final results from the Phase 3 PROTEUS study of ERLEADA in prostate cancer; successful Phase 3 results for an oncology blockbuster typically drive a 5-10% price impact, expected.
Executive Director Mr. Patrick Kin Wah Chan's retirement from the Board, effective May 31, 2026. This routine change is expected to have a low price impact (≥1%) as it is a standard leadership transition, scheduled.
The company announced the departure of a senior management member on May 30, 2026; such changes typically have minor immediate market impact, expected.
Announcement of strategic global licensing agreement with Pfizer for 12 cancer medicines ($10.5B total value); >10% price impact estimated due to massive deal size expected
The company announced positive pivotal data from two Phase III clinical trials (B-Well 1 and B-Well 2) for bepirovirsen for the treatment of chronic hepatitis B, which were presented at the 2026 European Association for the Study of the Liver (EASL) Congress and published in the New England Journal of Medicine.
RemeGen's shares were included in the MSCI China Index, effective after market close on May 29, 2026. Analysts estimate this will drive institutional demand with a price impact of at least 5%, estimated.
Announced on May 29, 2026, that a trustee purchased approximately 5.7 million shares on the open market between May 19 and May 29 for the company's share award scheme.
Ex-dividend date on May 29, 2026, for a final dividend of CNY 1.57927 per share for the year 2025; low importance as the price adjustment is expected to be >=1%.